Finally, activating somatic mutations in AKT1 cause Proteus syndrome (MIM 176920), a highly variable disorder of asymmetric overgrowth, tissue hyperplasia affecting multiple organs and increased tumour risk (Supplementary Material, Fig. S1) (11). Here, AKT1 is linked to Proteus syndrome.